4Barry BW. Is transdermal drug delivery research still important today? [J]. Editorial DDT, 2001, 6( 19 ) : 967.
5Wang FJ, Yang YY, Zhang XZ, et al. Cellulose acetate membranes for transdermal delivery of scopolamine base [J]. Mater. Sci. Eng. C, 2002, 20(1-2) : 93.
6Galer BS, Rowbotham MC, Perander J, et al. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study [ J ]. Pain, 1999, 80(3) : 533.
7Pae CU, Lira HK, Han C, et al. Selegiline transdermal system.. Current awareness and promise [ J]. Progress in Neuro-Psychopharmacology & Biological Psychiatry ,2007, 31 : 1153.
8Pham DQ, Nogid A. Rotigotine transdermal system for the treatment of parkinson' s disease [ J]. Clinical Therapeutics, 2008, 30(5) : 813.
9Lefevre G, Sedek G, Jhee S, et al. Pharmacokinetics and pharmacodynamics of the novel daily rivastigmine transdermal patch compared with twice-daily capsules in Alzheimerg disease patients [J]. Clila. Pharmacol . Ther. 2008, 83 : 106.
10Winblad B, Cummings J, Andreasen N, et al. A six-month, double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer 's disease-rivastigmine patch versus capsule[ J]. Int J Geriatr Psychatryi, 2007, 22 (5) : 456.
